Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CRM

Salesforce Revenue Jumps to $11.1 Billion

Salesforce opened fiscal 2027 with revenue of $11.1 billion for the three months ended April 30, 2026, up 13% from a year earlier.

Operating income rose to $2.3 billion from $1.9 billion, lifting operating margin to about 21% from about 20%.

Diluted earnings per share jumped to $2.42 from $1.59. The company said its $25 billion accelerated share repurchase program, executed in March 2026, led to the repurchase of about 103 million shares and added $0.14 to diluted EPS.

Cash from operations reached $6.7 billion, up 3% year over year. Salesforce ended the quarter with $11.8 billion of cash, cash equivalents and marketable securities.

Remaining performance obligation, a measure of contracted future revenue, stood at about $67.9 billion, up 11% year over year. Current remaining performance obligation was about $33.6 billion, up 14%.

Salesforce paid about $365 million in dividends and dividend equivalents during the quarter, down from $402 million a year earlier.

Subscription and support revenue accounted for about 95% of total revenue. Revenue from term software licenses made up less than 10% of subscription and support revenue.

The company said foreign exchange added about 2% to total revenue growth in the quarter and contributed 1% to current remaining performance obligation growth on a constant-currency basis.

Attrition, excluding Slack self-service, Informatica and current-year acquisitions, was about 8% as of April 30, 2026.

Salesforce said it saw sustained growth in Agentforce Apps and Data 360 during the quarter, with Informatica contributing to the Data 360 momentum. The market has reacted to these announcements by moving the company's shares 0.02% to a price of $179.115. For more information, read the company's full 10-Q submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS